Please login to the form below

Not currently logged in
Email:
Password:

crenezumab

This page shows the latest crenezumab news and features for those working in and with pharma, biotech and healthcare.

Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat

Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat

s crenezumab and Roche/Chugai’s gantenerumab.

Latest news

  • Glimmer of hope for amyloid drugs in Alzheimer's? Glimmer of hope for amyloid drugs in Alzheimer's?

    another amyloid-targeting drug called crenezumab heading into phase III testing after mixed results in earlier trials.

  • Double trial disappointment for Roche Double trial disappointment for Roche

    The company also has two other investigational medicines for the disease in phase II development: crenezumab, another anti-amyloid antibody, and RG1577, a monoamine oxidase-B inhibitor.

  • Mixed findings for Roche in Alzheimer's study Mixed findings for Roche in Alzheimer's study

    Crenezumab misses targets but shows some signs of activity. Roche's candidate drug for Alzheimer's disease (AD) crenezumab missed its targets in a phase II trial, but showed some signs ... Crenezumab was delivered as an intravenous infusion in the phase

  • Alzheimer's disease pipeline takes multiple hits Alzheimer's disease pipeline takes multiple hits

    in the EU, USA and South America); crenezumab (Genentech) that is being investigated in a long-term safety extension of phase II trials and a landmark AD prevention trial (see later); ... The first trial (organised by the Banner Alzheimer's Institute in

  • FDA explains draft Alzheimer's guidance in NEJM editorial FDA explains draft Alzheimer's guidance in NEJM editorial

    Lilly is also looking at earlier-stage intervention with solanezumab, while Genentech/AC Immune are going even further upstream by testing their crenezumab candidate in a healthy group of high-risk

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics